🇺🇸 Metformin + Insulin in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Acute Graft Versus Host Disease In Skin — 1 report (12.5%)
2. Anaemia — 1 report (12.5%)
3. Chronic Graft Versus Host Disease — 1 report (12.5%)
4. Covid-19 — 1 report (12.5%)
5. Myocardial Infarction — 1 report (12.5%)
6. Neutrophil Count Decreased — 1 report (12.5%)
7. Tendon Rupture — 1 report (12.5%)
8. Thrombosis — 1 report (12.5%)

Source database →

Frequently asked questions

Is Metformin + Insulin approved in United States?

Metformin + Insulin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Metformin + Insulin in United States?

University of Virginia is the originator. The local marketing authorisation holder may differ — check the official source linked above.